Pyronaridine
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
4-[(7-chloro-2-methoxy-pyrido[3,2-b]quinolin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol | |
Clinical data | |
Legal status | CLP (EU): Acute Tox. 3(H301), Eye Dam. 1 (H318), Repr. 2 (H361), Aquatic Chronic 4 (H413) |
Routes | Oral, intramuscular injection, intravenous therapy |
Identifiers | |
CAS number | 74847-35-1 |
ATC code | None |
PubChem | CID 5485198 |
ChemSpider | 10647812 |
UNII | TD3P7Q3SG6 |
ChEMBL | CHEMBL35228 |
Chemical data | |
Formula | C29H32ClN5O2 |
Mol. mass | 518.05 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Pyronaridine is an antimalarial drug. It was first synthesized in 1970 and has been in clinical use in China since the 1980s. It was first assayed by Adegoke and Babalola in 2006.[1]
References
- ↑ Chang C, Lin-Hua T, Jantanavivat C (1992). "Studies on a new antimalarial compound: pyronaridine". Trans R Soc Trop Med Hyg 86 (1): 7–10. doi:10.1016/0035-9203(92)90414-8. PMID 1566313.
Adegoke & Babalola 2006
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.